AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21725634 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 100 mg flurbiprofen axetil postoperative (Group B)
Number of subjects: 45
Study 21725634 — intervention group
Group type: COMPARATOR
Intervention: 100 mg flurbiprofen axetil preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group A)
Number of subjects: 45
Study 21725634 — intervention group
Group type: COMPARATOR
Intervention: 10 ml placebo preoperative, 10 μg/kg fentanyl + 10 ml placebo postoperative (Group C)
Number of subjects: 45
Study 18445098 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori screening and treatment
Number of subjects: 12530
Study 18445098 — intervention group
Group type: COMPARATOR
Intervention: Control group (unscreened)
Number of subjects: 12530
Study 16902311 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly or more frequent monitoring
Number of subjects: 363
Study 16902311 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular access monitoring (performed by clinics)
Number of subjects: 363
Study 16902311 — intervention group
Group type: COMPARATOR
Intervention: Different vascular access monitoring practices
Number of subjects: 363
Study 12499335 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of supplement (200 mg vitamin E, 300 mg vitamin C, 25 mg beta-carotene, 90 micro g Se, and 500 micro g vitamin A)
Number of subjects: 46
Study 12499335 — intervention group
Group type: COMPARATOR
Intervention: Low dose of supplement (10 mg vitamin E and 500 micro g vitamin A)
Number of subjects: 46
Study 12499335 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of supplement
Number of subjects: 46
Study 11004144 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump conventional surgery with normothermic CPB and cardioplegic arrest
Number of subjects: 200
Study 11004144 — intervention group
Group type: COMPARATOR
Intervention: Off-pump surgery on the beating heart
Number of subjects: 200
Study 8695246 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-RH analogue combined with a non-steroidal anti-androgen
Number of subjects: 63
Study 8695246 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy
Number of subjects: 63
Study 2003341 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin taken orally once a day for three days
Number of subjects: 0
Study 2003341 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim and sulfamethoxazole (TMP/SMX) taken orally twice a day for seven days
Number of subjects: 0
Study 6663617 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative tasks (walking, reaching, hand-eye coordination)
Number of subjects: 66
Study 6663617 — intervention group
Group type: COMPARATOR
Intervention: Eyeglass correction
Number of subjects: 66
Study 6663617 — intervention group
Group type: COMPARATOR
Intervention: Lens-implant or contact-lens correction
Number of subjects: 66
Study 31187045 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome prevalence
Number of subjects: 405
Study 31187045 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for metabolic syndrome
Number of subjects: 405
Study 28942334 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-μg rhPTH(1‐84) daily dose
Number of subjects: 42
Study 28942334 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-μg rhPTH(1‐84) daily dose
Number of subjects: 42
Study 25671024 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on training at 'Ultrafest' symposium
Number of subjects: 48
Study 24379356 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical decompression of the tibial nerve
Number of subjects: 42
Study 24379356 — intervention group
Group type: COMPARATOR
Intervention: Control leg (no intervention)
Number of subjects: 42
Study 24379356 — intervention group
Group type: EXPERIMENTAL
Intervention: Operated leg (surgical decompression)
Number of subjects: 42
Study 22079995 — intervention group
Group type: EXPERIMENTAL
Intervention: Col diet (bovine colostrum)
Number of subjects: 832
Study 22079995 — intervention group
Group type: EXPERIMENTAL
Intervention: Col‐6d diet (bovine colostrum for 6 days)
Number of subjects: 832
Study 22079995 — intervention group
Group type: EXPERIMENTAL
Intervention: Col‐4d diet (bovine colostrum for 4 days)
Number of subjects: 832
Study 18805726 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbopelvic joint manipulation
Number of subjects: 42
Study 18805726 — intervention group
Group type: COMPARATOR
Intervention: 1 min lumbar passive range of motion (PROM)
Number of subjects: 42
Study 18805726 — intervention group
Group type: COMPARATOR
Intervention: Prone extension on elbows for 3 min
Number of subjects: 42
Study 17468682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood-congruent psychotic symptoms
Number of subjects: 0
Study 17468682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood-incongruent psychotic symptoms
Number of subjects: 0
Study 17468682 — intervention group
Group type: EXPERIMENTAL
Intervention: Both subtypes (mood-congruent and mood-incongruent)
Number of subjects: 0
Study 17468682 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacious treatment
Number of subjects: 0
Study 15247729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cook 12Fr Perc‐NCircle (38 cm)
Number of subjects: 3
Study 15247729 — intervention group
Group type: COMPARATOR
Intervention: Storz 3‐prong grasper (27090RB)
Number of subjects: 3
Study 11305822 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 1 mg x kg(‐1) iv 30 min before surgery (PRE)
Number of subjects: 45
Study 11305822 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 1 mg x kg(‐1) iv at the end of surgery (POST)
Number of subjects: 45
Study 11305822 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CONT)
Number of subjects: 45
Study 9228808 — intervention group
Group type: EXPERIMENTAL
Intervention: Short duration masker (10 ms)
Number of subjects: 4
Study 9228808 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level standards with short duration masker and standard
Number of subjects: 4
Study 9228808 — intervention group
Group type: EXPERIMENTAL
Intervention: Second tone at 4.133 kHz presented simultaneously with the 1.0 kHz masker
Number of subjects: 4
Study 7948340 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-led smoking prevention program
Number of subjects: 2366
Study 7948340 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led smoking prevention program
Number of subjects: 2366
Study 3598225 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% of the standard im dose of HDCV
Number of subjects: 154
Study 3598225 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% of the standard im dose of HDCV
Number of subjects: 154
Study 3598225 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% of the standard im dose of HDCV
Number of subjects: 154
Study 3598225 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% of the standard im dose id of HDCV
Number of subjects: 154
Study 3598225 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% of the standard im dose id of HDCV
Number of subjects: 154
Study 31396820 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent Tracking (≥6 out of 7 days for at least 75% of the targeted weeks)
Number of subjects: 100
Study 31396820 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent Tracking
Number of subjects: 100
Study 28715806 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time volume contrast imaging in the A plane (VCI-A)
Number of subjects: 100
Study 28715806 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-dimensional ultrasound (2D)
Number of subjects: 100
Study 28715806 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VCI-A and 2D for malformed fetuses
Number of subjects: 100
Study 26471432 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate + Citalopram
Number of subjects: 35
Study 26471432 — intervention group
Group type: COMPARATOR
Intervention: Citalopram + Placebo
Number of subjects: 35
Study 26471432 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate + Placebo
Number of subjects: 35
Study 25701333 — intervention group
Group type: EXPERIMENTAL
Intervention: Low AGE diet
Number of subjects: 43
Study 25701333 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with habitual food intake
Number of subjects: 43
Study 25701333 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus low AGE diet
Number of subjects: 43
Study 23818758 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose inhaled corticosteroids (ICS) in combination with long-acting beta-agonist (LABA) for one month, then shifted to guideline doses.
Number of subjects: 156
Study 23818758 — intervention group
Group type: COMPARATOR
Intervention: Guideline doses (GD) therapy alone.
Number of subjects: 156
Study 20524439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (0.5 mg or 1 mg orally twice daily)
Number of subjects: 30
Study 20524439 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (200 microg inhaled twice daily)
Number of subjects: 30
Study 19006630 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based pulmonary rehabilitation
Number of subjects: 51
Study 19006630 — intervention group
Group type: COMPARATOR
Intervention: Home pulmonary rehabilitation
Number of subjects: 51
Study 16600723 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily for 24 months
Number of subjects: 2802
Study 16600723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2802
Study 16600723 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 2802
Study 12677572 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP/SMZ (TMP 4 mg/kg/d and SMZ 20 mg/kg/d, divided in 2 doses)
Number of subjects: 19
Study 12677572 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin (25 mg/kg/d, qid, 4 days a week)
Number of subjects: 19
Study 12677572 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical control, no long-term prophylaxis)
Number of subjects: 19
Study 12677572 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP/SMZ
Number of subjects: 19
Study 12677572 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin
Number of subjects: 19
Study 12677572 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP/SMZ vs Neomycin
Number of subjects: 19
Study 10958815 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole‐meal rye bread
Number of subjects: 17
Study 10958815 — intervention group
Group type: COMPARATOR
Intervention: White wheat bread
Number of subjects: 17
Study 9066329 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed endotracheal tubes sized by a new formula
Number of subjects: 488
Study 9066329 — intervention group
Group type: COMPARATOR
Intervention: Uncuffed endotracheal tubes sized by the modified Cole's formula
Number of subjects: 488
Study 9066329 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed endotracheal tubes
Number of subjects: 488
Study 9066329 — intervention group
Group type: COMPARATOR
Intervention: Uncuffed endotracheal tubes
Number of subjects: 488
Study 8373610 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 (0.11 +/- 0.03 micrograms/kg/min) infusion
Number of subjects: 57
Study 8373610 — intervention group
Group type: COMPARATOR
Intervention: Normotensive anesthesia
Number of subjects: 57
Study 2942511 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilizing exercises
Number of subjects: 36
Study 2942511 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercises
Number of subjects: 36
Study 2942511 — intervention group
Group type: COMPARATOR
Intervention: Attention-placebo control procedure
Number of subjects: 36
Study 31288781 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized exercise programs (CEPs) implemented by physical therapists
Number of subjects: 50
Study 31288781 — intervention group
Group type: COMPARATOR
Intervention: Commonly prescribed exercises (Control)
Number of subjects: 50
Study 27426276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (titrated from 0.09 to 0.54 mg, o.d., for 3 weeks)
Number of subjects: 13
Study 27426276 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 13
Study 27426276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 13
Study 26474759 — intervention group
Group type: EXPERIMENTAL
Intervention: Toolkit presented in paper and electronic form, including a training webinar
Number of subjects: 29
Study 26474759 — intervention group
Group type: EXPERIMENTAL
Intervention: Toolkit plus in-person training with a focus on practice change and change management strategies
Number of subjects: 29
Study 26474759 — intervention group
Group type: EXPERIMENTAL
Intervention: Toolkit, in-person training, plus practice facilitation with on-site visits
Number of subjects: 29
Study 23702394 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking with handrail support
Number of subjects: 24
Study 23702394 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground walking with support
Number of subjects: 24
Study 23702394 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal gait parameters (stride time, symmetry index)
Number of subjects: 24
Study 21672398 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy change restricting sale of sugar-sweetened beverages in schools
Number of subjects: 2033
Study 21672398 — intervention group
Group type: COMPARATOR
Intervention: National trends (NHANES)
Number of subjects: 2033
Study 19670303 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel stent
Number of subjects: 274
Study 19670303 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus stent
Number of subjects: 274
Study 19670303 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 274
Study 17216435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (250 mg base daily for 3 days, then 250 mg weekly for 6 months)
Number of subjects: 1111
Study 15161780 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted provider-level intervention (six monthly visits by a multidisciplinary health care team)
Number of subjects: 372
Study 15161780 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted provider-level intervention
Number of subjects: 372
Study 15161780 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 372
Study 11394470 — intervention group
Group type: EXPERIMENTAL
Intervention: Compatible chord code (ECC) for inputting Chinese characters
Number of subjects: 0
Study 11394470 — intervention group
Group type: COMPARATOR
Intervention: Randomly mapped code for inputting Chinese characters
Number of subjects: 0
Study 9738734 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed nasal cannula delivery of nitric oxide (NO)
Number of subjects: 8
Study 9738734 — intervention group
Group type: COMPARATOR
Intervention: Continuous mask delivery of nitric oxide (NO)
Number of subjects: 8
Study 7986964 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsemide 5 mg
Number of subjects: 17
Study 7986964 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsemide 10 mg
Number of subjects: 17
Study 7986964 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsemide 20 mg
Number of subjects: 17
Study 7986964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 3192843 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate
Number of subjects: 18
Study 8151005 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 88
Study 8151005 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 88
Study 8151005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 358877 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 39
Study 358877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 358877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study 30689618 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-emitting diode therapy (LEDT) applied to biceps brachii after strength training
Number of subjects: 45
Study 30689618 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham LEDT applied to biceps brachii after strength training
Number of subjects: 45
Study 30689618 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 45
Study 25307829 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary group-based rehabilitation program with monthly motivational consultation
Number of subjects: 165
Study 25307829 — intervention group
Group type: COMPARATOR
Intervention: Oral drug treatment alone
Number of subjects: 165
Study 25307829 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary group-based rehabilitation program
Number of subjects: 165
Study 25715157 — intervention group
Group type: EXPERIMENTAL
Intervention: CPS5‐TT/CPS8‐TT/AT/ClfA vaccine (5/5/10/10 μg or 10/10/30/30 μg dose with or without AS03B adjuvant)
Number of subjects: 88
Study 25715157 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 88
Study 23265571 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 104
Study 23265571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 21333346 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose maintenance vaccine (4200 allergen units, approximately 70 μg of Der f 1/d)
Number of subjects: 31
Study 21333346 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose maintenance vaccine (60 allergen units, approximately 1 μg of Der f 1/d)
Number of subjects: 31
Study 21333346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 19833591 — intervention group
Group type: EXPERIMENTAL
Intervention: LAD revascularization first (Group 1)
Number of subjects: 40
Study 19833591 — intervention group
Group type: COMPARATOR
Intervention: RCA revascularization first (Group 2)
Number of subjects: 40
Study 17560423 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic total colectomy for patients with chronic ulcerative colitis (UC)
Number of subjects: 0
Study 17560423 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive management options
Number of subjects: 0
Study 17560423 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance colonoscopy techniques
Number of subjects: 0
Study 17560423 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention
Number of subjects: 0
Study 17560423 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance guidelines
Number of subjects: 0
Study 14660478 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribose (200 mg/kg body wt; Rib)
Number of subjects: 8
Study 14660478 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 8
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking cervical spine pain and stiffness, headache, scapular or arm pain
Number of subjects: 812
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking headache
Number of subjects: 812
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Age effect on waking headache
Number of subjects: 812
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking cervical pain, stiffness, and headache in females
Number of subjects: 812
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking cervical pain, stiffness, and headache in males
Number of subjects: 812
Study 11869160 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking with aching between the scapulae or in the arm
Number of subjects: 812
Study 9822512 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 900 mg every 8 hours and gentamicin 1.5 mg/kg every 8 hours until afebrile for a minimum of 24 hours (group 2)
Number of subjects: 116
Study 9822512 — intervention group
Group type: COMPARATOR
Intervention: No scheduled postoperative antibiotics (group 1)
Number of subjects: 116
Study 7853818 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrozepin treatment
Number of subjects: 45
Study 7853818 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranisan treatment
Number of subjects: 45
Study 7853818 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 patients)
Number of subjects: 45
Study 2912419 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic catheter
Number of subjects: 51
Study 2912419 — intervention group
Group type: COMPARATOR
Intervention: Standard pulmonary artery catheter
Number of subjects: 51
Study 4597719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephapirin
Number of subjects: 20
Study 4597719 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 20
Study 30841744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy augmented with movement or occupational therapy (n=23)
Number of subjects: 50
Study 30841744 — intervention group
Group type: COMPARATOR
Intervention: Computerized cognitive training (n=27)
Number of subjects: 50
Study 28625506 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 0
Study 28625506 — intervention group
Group type: COMPARATOR
Intervention: lixisenatide 20 μg
Number of subjects: 0
Study 25792607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass isoniazid preventive therapy for 9 months
Number of subjects: 0
Study 25792607 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized intervention (increased implementation characteristics)
Number of subjects: 0
Study 25792607 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional interventions (improving diagnostics, reducing treatment delay, providing continuous isoniazid preventive therapy to HIV-positive people, scaling up antiretroviral treatment coverage)
Number of subjects: 0
Study 24370263 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised, home-based nutritional counselling by trained Community Health Workers on maternal, infant and young child nutrition (MIYCN)
Number of subjects: 780
Study 24370263 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 780
Study 21692770 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Practitioners (NPs)
Number of subjects: 0
Study 21692770 — intervention group
Group type: COMPARATOR
Intervention: Dermatologists
Number of subjects: 0
Study 18165596 — intervention group
Group type: EXPERIMENTAL
Intervention: IV patient-controlled morphine
Number of subjects: 126
Study 18165596 — intervention group
Group type: EXPERIMENTAL
Intervention: IV patient-controlled pethidine
Number of subjects: 126